Analytical Scientist at Bristol-Myers Squibb

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

B.Sc. or M.Sc. in Analytical Chemistry, Pharmaceutical Sciences, or relevant scientific field
Minimum 5 years of experience in analytical method development, validation, verification, and transfer in the pharmaceutical or radiopharmaceutical industry
Strong knowledge of analytical techniques such as UHPLC, HPLC, GC, TLC, ICP, LC-MS, Gamma Spectrometry, Alpha Spectrometry, and others
Ability to work with and around ionizing radiation and hazardous chemicals
Availability for extended hours or weekend work based on radiopharmaceutical manufacturing schedule (predominantly first shift, M-F)

Responsibilities

Develop and validate analytical methods for parenteral radiopharmaceutical products according to phase appropriate guidelines, including UHPLC, HPLC, GC, TLC, ICP, LC-MS, Gamma Spectrometry, Alpha Spectrometry, and other techniques as required
Participate in method transfer activities from CDMO or internal research facility to QC team, ensuring accuracy and reliability of data
Prepare analytical test methods and method validation, verification, and transfer protocols and reports in accordance with applicable guidelines and industry standards (e.g. USP, EP, and ICH)
Work closely with other teams to ensure timely delivery of analytical results and support product development and commercialization
Participate in troubleshooting and investigations of analytical issues, identify root causes, and implement corrective actions
Develop and maintain appropriate documentation, including notebooks, protocols, reports, standard operating procedures and associated forms, and data analysis
Participate in instrument qualification, calibration, and maintenance activities
Ensure compliance with GMP regulations, safety guidelines, and quality standards
Work with RSO to ensure laboratory compliance with the radiation safety programs
Provide technical support to other teams or business units as required
Source and on-board analytical technologies as required
Perform other duties as required by management

Skills

Method Development

Method Validation

Method Transfer

Stability Testing

Analytical Chemistry

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free